Decision-making for PCV in adults

Thirteen-valent pneumococcal conjugate vaccine (PCV13) was licensed in adults to address the unmet medical need of vaccine-type community acquired pneumonia (CAP) and the limitations of previous plain-polysaccharide vaccines. Since then, some have questioned the utility of adult PCV13 use, arguing t...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, John M., Swerdlow, David L., Isturiz, Raul E., Jodar, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605720/
https://www.ncbi.nlm.nih.gov/pubmed/30352017
http://dx.doi.org/10.1080/21645515.2018.1538611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605720/
https://www.ncbi.nlm.nih.gov/pubmed/30352017
http://dx.doi.org/10.1080/21645515.2018.1538611

Ejemplares similares